Navigation Links
Abbott Named One of the 'Top Employers' in the Biotech and Pharmaceutical Industry by Science Magazine

Abbott Named One of the 'Top Employers' in the Biotech and Pharmaceutical... -- ABBOTT PARK, Ill., Oct. 7 /PRNewswire/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Magazines, Publishing & Information Services, Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Awards, Surveys, Polls and Research Click to view news release full screen  

Abbott Named One of the 'Top Employers' in the Biotech and Pharmaceutical Industry by Science Magazine


ABBOTT PARK, Ill., Oct. 7 /PRNewswire/ -- Abbott (NYSE: ABT) today was named one of the top 20 employers in Science magazine's 2010 Top Biopharma Employers survey.  The annual survey seeks to identify the companies with the best reputations as employers.  According to the survey, Abbott's top three driving characteristics were: clear vision, loyal employees, and does important, quality research. The complete rankings are available online and in the Oct. 8, 2010 issue of Science.

"At Abbott, science is the foundation of our success and every day thousands of Abbott scientists work to find meaningful solutions for patients around the world," said John Leonard, M.D., senior vice president, pharmaceuticals, research and development, Abbott and chair of Abbott's scientific governing board.  "Abbott is proud to be included on Science magazine's list of top employers.  The ranking is further evidence that we have been successful in our effort to create a creative, collaborative scientific organization that encourages and rewards innovative thinking."

At Abbott, all employees are given opportunities to succeed, lead and grow in their careers through training, mentoring, networking groups and extensive development programs.  Abbott scientists are rewarded through the Chairman's awards, President's awards, patent/inventor awards and induction into the prestigious Volwiler Society, which was established in 1985 to recognize the company's most distinguished scientists and engineers.  Each year, the Volwiler Society issues "Outstanding Research" awards to the Abbott scientists and teams who have made significant contributions to their scientific fields.

About the Science SurveyScience's annual survey of Top Employers polls employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the driving characteristics of the best employers and to determine the 20 best employers in these industries.  Respondents to the web-based survey were asked to rate companies based on 23 characteristics, including financial strength, easy adaptation to change, and a research-driven environment.  The study was conducted and rankings were determined by an independent research firm commissioned by the business office of the journal.

Abbott Widely Recognized as a Premier Employer In addition to the Science ranking, Abbott also has been recognized as a top employer for scientists by The Scientist magazine six times and was the highest ranked health care company on The Scientist's 2010 list.  Abbott also has been one of Working Mother magazine's "100 Best Companies" for ten consecutive years and has been named a great place to work in more than 20 countries around the world.  Additionally, FORTUNE has named Abbott as one of "America's Most Admired Companies" every year since the list's inception in 1983, including naming Abbott the No. 1 Most Admired Company in its industry sector in 2010, in part for the company's strong performance in people management.  

About Abbott Abbott is a global, broad-based health care company devoted to the discovery, development, manufacturing and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.  

Abbott's news releases and other information are available on the company's Web site at


Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution
2. Abbotts XIENCE V® Shows Continued Strong Performance in Key Safety and Efficacy Measures at Two Years in Investigator-Initiated COMPARE Trial
3. Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S.
4. Abbotts Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
5. The Deal Names Abbott Top Dealmaker for Third Consecutive Year
6. Abbott Declares 347th Consecutive Quarterly Dividend
7. Abbott to Present Data on Market-Leading XIENCE V® and Promising Vascular Pipeline at TCT 2010
8. Abbott Statement on the FDA Advisory Committee Recommendation on Sibutramine
9. Abbott Honored for Workplace Leadership for the Tenth Consecutive Year by Working Mother Magazine
10. Abbott Included on the Dow Jones Sustainability Indexes for Six Consecutive Years in Recognition of Leading Corporate Citizenship Performance
11. Abbott Completes Acquisition of Piramals Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India
Post Your Comments:
(Date:11/30/2015)... 30, 2015 Cumberland Pharmaceuticals (CPIX), today announced that ... on December 3, 2015. TIME: 3:15p.m. ET ... ET LINK: --> DATE: ... --> --> ... are invited to ask the company questions in real-time - ...
(Date:11/30/2015)... -- Varian Medical Systems (NYSE: VAR ) has signed a ... Hospitals Group, the largest hospital chain in India ... in the country. The MoU was signed by Dr. K. ... Kakkar , Varian,s India managing director, in ... , Varian intends to deploy its Access to Care program by ...
(Date:11/30/2015)... and BOSTON , November 30, 2015 ... develop potential new medicines directed at up to 10 ... --> PFE ) to research and develop ... protein-coupled receptor (GPCR) targets across multiple therapeutic areas. ... drug discovery and development company and wholly-owned subsidiary of ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... ... additions to its industry-leading suite of automated breast density assessment and enterprise ... (RSNA) meeting, November 29-December 4, 2015 (South Hall booth #2377). Volpara’s quantitative ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... Kreithen”), one of the leading plastic surgery practices in Florida, is proud to ... to consult for surgical innovations giant Ethicon Inc., a Johnson & Johnson Company. ...
(Date:11/30/2015)... ... 30, 2015 , ... The successful filing of an Investigational New Drug application ... important to this key industry segment, Regis Technologies has decided to sponsor and participate ... at 11am EST. , Federal law does not allow new drugs to cross state ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... assets of DataTrade Solutions Inc., a Healthcare IT consulting, development and support company. ... programming and technical experience available within DataTrade to extend the services currently provided ...
(Date:11/30/2015)... ... November 30, 2015 , ... GKhair & Tibolli team members and ... Beauty Show held on November 8th and 9th at the Puerto Rico Convention Center, ... artists, renowned beauticians and top of the line fashion journalists. The San Juan Beauty ...
Breaking Medicine News(10 mins):